PitchSend

Investor Presentaiton

29 29 CD8+ T Cell Infiltration into Tumor Following MEDI0457 Treatment Post MEDI0457 Pre MEDI0457 Pt: 045-509 Pt: 045-524 Robust antigen-specific CD8+ killer T cell responses observed in 20/22 90.1% of patients (both tumor tissue and peripheral blood) Aggarwal et al Clinical Cancer Research 2018 "Cold" "Hot" CD8+ T Cell Infiltration INOVIO POWERING DNA MEDICINES

View entire presentation